MSI Methylation Sciences
Burnaby
About MSI Methylation Sciences
MSI Methylation Sciences Inc. operates as a biotechnology company. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in West Vancouver, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $48.4M
- Last round: Series Unknown (Oct 2016)
- Website: methylationsciences.com
- Phone: (604) 435-5155
Industries & Categories
Biotechnology, Dietary Supplements, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/msi-methylation-sciences-122707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.